Home » Favipira

Trial finds Favipira effective for treating mild, moderate Covid-19 patients

96% of the patients who participated in the clinical trial were cured by the anti-flu drug, according to medical professionals involved with the trial A limited-scale clinical trial has found Favipira, an antiviral drug to treat influenza, to be effective in treating patients with mild to moderate Covid-19 symptoms. Around 96% patients who participated in [...]

By |2020-07-16T06:34:05+00:00July 16th, 2020|Media & Announcements|0 Comments

Covid-19 Patients: Favipiravir effective in Dhaka trial

The Bangladesh Society of Medicine (BSM) has found effectiveness of Favipiravir as a clinically proven drug for the treatment of Covid-19 patient. After ending trial in Wuhan province of China and Russia, the Dhaka trial revealed similar effectiveness of Favipiravir in treating Covid-19 infected patients. The BSM found around 96 percent patients to be Covid-19 [...]

By |2020-07-16T06:31:18+00:00July 16th, 2020|Media & Announcements|0 Comments

Beacon produces antiviral drug Favipiravir to fight Covid-19

Beacon Pharmaceuticals Limited has developed an antiviral drug Favipiravir, better known as Avigan, accelerating treatment for the people infected with the novel coronavirus (Covid-19). In 2014, Fujifilm Toyama Chemical Company invented the drug first in Japan and the drug was used in treating the people who were infected with Ebola virus, said a press release [...]

By |2020-07-22T05:17:22+00:00July 12th, 2020|Media & Announcements|0 Comments